Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies.

[1]  A. Uy‐Evanado,et al.  Abstract 16081: What is the Societal Impact of Sudden Cardiac Death in the United States? , 2012 .

[2]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[3]  Peter C Austin,et al.  Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. , 2009, JAMA.

[4]  C. O'connor,et al.  Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. , 2009, Heart rhythm.

[5]  G. Fonarow,et al.  Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of IMPROVE HF , 2009 .

[6]  J. Conti,et al.  Effective Management of ICD Patient Psychosocial Issues and Patient Critical Events , 2009, Journal of cardiovascular electrophysiology.

[7]  C. Cannon,et al.  Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly: Findings From the Get With the Guidelines Quality-Improvement Program , 2009, Circulation. Cardiovascular quality and outcomes.

[8]  C. Yancy,et al.  Use of aldosterone antagonists in heart failure. , 2009, JAMA.

[9]  H. Krumholz,et al.  Racial differences in survival after in-hospital cardiac arrest. , 2009, JAMA.

[10]  H. Ghanbari,et al.  Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. , 2009, Archives of internal medicine.

[11]  G. Fonarow,et al.  Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). , 2009, The American journal of cardiology.

[12]  M. Walsh,et al.  Sudden cardiac arrest prevention pathways and tools. , 2009, Critical pathways in cardiology.

[13]  H. Krumholz,et al.  Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator. , 2009, JAMA.

[14]  J. Birkmeyer,et al.  Racial and gender trends in the use of implantable cardioverter-defibrillators among Medicare beneficiaries between 1997 and 2003. , 2009, Congestive heart failure.

[15]  T. Mader.  Racial differences in survival after in-hospital cardiac arrest , 2009 .

[16]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[17]  Kevin L. Thomas,et al.  Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. , 2008, American heart journal.

[18]  C. Callaway,et al.  Regional variation in out-of-hospital cardiac arrest incidence and outcome. , 2008, JAMA.

[19]  C. O'connor,et al.  Heart Failure Care in the Outpatient Cardiology Practice Setting: Findings From IMPROVE HF , 2008, Circulation. Heart failure.

[20]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[21]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[22]  K. Schulman,et al.  Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. , 2007, JAMA.

[23]  C. Yancy,et al.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.

[24]  Kevin L. Thomas,et al.  Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of , 2007, The American journal of cardiology.

[25]  S. Galea,et al.  Explaining racial disparities in incidence of and survival from out-of-hospital cardiac arrest. , 2007, American journal of epidemiology.

[26]  C. O'connor,et al.  Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. , 2007, American heart journal.

[27]  Robert M Califf,et al.  Curbing the cardiovascular disease epidemic: aligning industry, government, payers, and academics. , 2007, Health affairs.

[28]  G. Fonarow,et al.  Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2007, American heart journal.

[29]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[30]  B. Knight,et al.  Disparities in the use of primary prevention and defibrillator therapy among blacks and women. , 2006, The American journal of medicine.

[31]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[32]  A. Laupacis,et al.  Risk-treatment mismatch in the pharmacotherapy of heart failure. , 2005, JAMA.

[33]  C. Yancy,et al.  Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. , 2005, Archives of internal medicine.

[34]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[35]  P. Heidenreich,et al.  Trends in implantable cardioverter-defibrillator racial disparity: the importance of geography. , 2005, Journal of the American College of Cardiology.

[36]  G. Fonarow.  Strategies to improve the use of evidence-based heart failure therapies. , 2005, Reviews in cardiovascular medicine.

[37]  Mohamud Daya,et al.  Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. , 2004, Journal of the American College of Cardiology.

[38]  C. O'connor,et al.  Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.

[39]  G. Fonarow.  Strategies to improve the use of evidence-based heart failure therapies: OPTIMIZE-HF. , 2004, Reviews in cardiovascular medicine.

[40]  P. Heidenreich,et al.  Racial Disparity in Cardiac Procedures and Mortality Among Long‐Term Survivors of Cardiac Arrest , 2003, Circulation.

[41]  B. Pitt,et al.  Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[42]  M. Copass,et al.  Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. , 2002, JAMA.

[43]  G. Guyatt,et al.  Clinical expertise in the era of evidence-based medicine and patient choice. , 2002, Vox sanguinis.

[44]  C. Silagy,et al.  The effectiveness of local adaptation of nationally produced clinical practice guidelines. , 2002, Family practice.

[45]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[46]  Gordon H Guyatt,et al.  Clinical expertise in the era of evidence-based medicine and patient choice , 2002, ACP journal club.

[47]  G. Fonarow.  Clinical diagnosis and prognosis of acute limb ischemia. , 2002 .

[48]  G. Fonarow.  The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes. , 2002, Reviews in cardiovascular medicine.

[49]  George A. Mensah,et al.  Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.

[50]  T. Walley,et al.  Why do GPs not implement evidence-based guidelines? A descriptive study. , 2001, Family practice.

[51]  R. Virmani,et al.  Sudden cardiac death. , 1987, Human pathology.

[52]  John Wikstrand,et al.  Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) , 2000 .

[53]  B. Pitt,et al.  The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .

[54]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[55]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[56]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[57]  P. Stolley.  Racial differences in the outcome of left ventricular dysfunction. , 1999, The New England journal of medicine.

[58]  M. Zack,et al.  Comparison of sudden and nonsudden coronary deaths in the United States. , 1996, Circulation.

[59]  D. Hosmer,et al.  A Communitywide Perspective of Sex Differences and Temporal Trends in the Incidence and Survival Rates After Acute Myocardial Infarction and Out‐of‐Hospital Deaths Caused by Coronary Heart Disease , 1993, Circulation.

[60]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[61]  R. Gillum,et al.  Sudden coronary death in the United States: 1980-1985. , 1989, Circulation.

[62]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[63]  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1987, The New England journal of medicine.

[64]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.